Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Studies explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.
As part of the University of Oxford\u2019s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.
New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.
Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.
A new study published in Circulation Research by researchers at the Kennedy Institute shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.
Researchers at the Kennedy Institute join a collaboration to find new \u2018drug-free\u2019 ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Professor Michael Dustin and an international team of collaborators have been awarded a \u20ac10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.
Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.
The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.
It\u2019s International Womens Day! This year\u2019s theme is #Choosetochallenge. We\u2019re celebrating some of the amazing women at NDORMS, and asking them what changes they\u2019d like to see in medical sciences over the next 100 years.
The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.
New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.
![\"Two](\"https://www.kennedy.ox.ac.uk/news/unlocking-the-secrets-of-the-microbiome/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n